Fully funded by 
Content independently selected
Reduced complications, wound pain, and mortality in D2 gastrectomy.
Randomized phase 2 study compares 4 different regimens.
Gastric cancer is often fatal when diagnosed, making early detection and management crucial.
Interventions needed to increase awareness.
BMI also linked to operative time, postoperative complications.
Postoperative grade ≥3 morbidity halved in phase 3 trial.
ORR was 57.1% and 76.5% with nivolumab plus SOX and CapeOX, respectively.
Combination drug was previously approved for colorectal cancer.
Most patients experienced reduced bleeding.
Novel nomogram outperforms pTN in predicting OS.
D2 dissection is recommended for gastric cancer, but can be challenging.
Data from the phase 3 KLASS-01 randomized trial.
No PFS benefit in patients receiving cisplatin plus fluoropyrimidine chemotherapy.
Clinical characteristics could guide strategy.
Presence can help determine surgical strategy.
The role of continuing perioperative chemotherapy post-surgery in oesophageal or gastroesophageal junction adenocarcinoma
Nomogram of CT phenotypes and Lauren type shows excellent prognostic value.
